Apyx Medical Corporation, a Clearwater, Florida-based company specializing in innovative medical technologies, has recently announced a significant milestone in its research efforts. The company revealed the publication of a peer-reviewed article in the journal ’Plastic and Reconstructive Surgery - Global Open’. This article details a clinical study that compared the effectiveness of Apyx Medical’s proprietary Renuvion Helium Plasma Technology against InMode’s Bipolar RF System in patients undergoing liposuction or body contouring procedures.
The study highlights how Renuvion’s helium plasma technology may offer distinct advantages in post-procedure healing and skin tightening compared to the Bipolar RF system. Specific outcomes discussed in the publication could potentially influence the clinical adoption of these technologies in cosmetic and reconstructive procedures.
In addition to the clinical advancements, Apyx Medical Corporation has reported robust financial performance. The company recorded a year-over-year revenue increase of 29.02%. Sequentially, revenue grew by 9.36%, reflecting a strong demand for its products and services. This growth has been noted amidst both the launch of new technologies and the continued expansion of the company’s market presence.
These developments may position Apyx Medical Corporation favorably in the competitive landscape of medical technology, particularly in the field of aesthetic procedures, where innovation is critical.
The dual focus on clinical publications and strong financial growth underscores Apyx Medical’s strategic efforts to enhance its product offerings while achieving commercial success. As the company continues to advance its Renuvion technology and its presence in the market, it remains to be seen how these factors will influence future growth and innovation in the field of cosmetic surgery.
Comments